These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9577733)

  • 1. Sensitivity of primary screening by rapid review: 'to act or not to act on the results, that is the question'.
    Slater DN
    Cytopathology; 1998 Apr; 9(2):77-83. PubMed ID: 9577733
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid review.
    Faraker CA
    Cytopathology; 1998 Apr; 9(2):71-6. PubMed ID: 9660635
    [No Abstract]   [Full Text] [Related]  

  • 3. The sensitivity of rapid (partial) review of cervical smears.
    Shield PW; Cox NC
    Cytopathology; 1998 Apr; 9(2):84-92. PubMed ID: 9577734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An operative model: verification of the quality of the screening Pap test ].
    Montanari GR; Arnaud S; Berardengo E; Campione D; Cozzani C; Parisio F; Viberti L; Ghiringhello B
    Pathologica; 2001 Oct; 93(5):609-10. PubMed ID: 11725370
    [No Abstract]   [Full Text] [Related]  

  • 5. Partial rescreening of all negative smears: an improved method of quality assurance in laboratories undertaking cervical screening.
    Faraker CA
    Cytopathology; 1993; 4(1):47-50. PubMed ID: 8453016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid rescreening.
    Rubin A
    Cytopathology; 1998 Apr; 9(2):141-2. PubMed ID: 9577744
    [No Abstract]   [Full Text] [Related]  

  • 7. Invited commentary--Rapid review: current practice.
    Faraker CA
    Cytopathology; 2001 Aug; 12(4):249-50. PubMed ID: 11488873
    [No Abstract]   [Full Text] [Related]  

  • 8. Internal quality assurance of sensitivity of primary screening.
    Boxer ME
    Cytopathology; 1998 Oct; 9(5):349-50. PubMed ID: 9800134
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid pre-screening: a validated quality assurance measure in cervical cytology.
    Smith J; Nicholas D; Boyd K; Deacon-Smith R
    Cytopathology; 2003 Oct; 14(5):275-80. PubMed ID: 14510892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cervical cancer screening. False negative smears].
    Vassilakos P; De Marval F; Muñoz M
    Rev Med Suisse Romande; 1997 Aug; 117(8):597-601. PubMed ID: 9340714
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid screening of cervical smears as a method of internal quality control. For how long should we rescreen?
    Farrell DJ; Bilkhu S; Gibson LM; Cummings L; Wadehra V
    Acta Cytol; 1997; 41(2):251-60. PubMed ID: 9100751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in the routine screening of cervical smears: A study using rapid prescreening and 100% rapid review as internal quality control methods.
    Tavares SB; Alves de Sousa NL; Manrique EJ; Pinheiro de Albuquerque ZB; Zeferino LC; Amaral RG
    Cancer Cytopathol; 2011 Dec; 119(6):367-76. PubMed ID: 21954191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cytology EQA--the Northern experience.
    Llewellyn H
    Cytopathology; 2001 Aug; 12(4):272-3. PubMed ID: 11512548
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid screening: a comparative study.
    Dudding N; Hewer EM; Lancucki L; Rice S
    Cytopathology; 2001 Aug; 12(4):235-48. PubMed ID: 11488872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achievable standards, benchmarks for reporting and criteria for evaluating cervical cytopathology.
    Dalla Palma P
    Cytopathology; 1997 Jun; 8(3):210. PubMed ID: 9202897
    [No Abstract]   [Full Text] [Related]  

  • 16. Does cervical cancer screening do more harm than good?
    Payne L; Lavis P
    Nurs Times; 2001 Jul 19-25; 97(29):20. PubMed ID: 11957496
    [No Abstract]   [Full Text] [Related]  

  • 17. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme.
    Coleman D; Day N; Douglas G; Farmery E; Lynge E; Philip J; Segnan N
    Eur J Cancer; 1993; 29A Suppl 4():S1-38. PubMed ID: 8274301
    [No Abstract]   [Full Text] [Related]  

  • 18. Internal quality assurance in cervical cytology one laboratory's experience.
    Cross PA
    Cytopathology; 1996 Feb; 7(1):25-31. PubMed ID: 8833871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicolegal affairs. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    Frable WJ; Austin RM; Greening SE; Collins RJ; Hillman RL; Kobler TP; Koss LG; Mitchell H; Perey R; Rosenthal DL; Sidoti MS; Somrak TM
    Acta Cytol; 1998; 42(1):76-119; discussion 120-32. PubMed ID: 9479326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A smear on audit. Implications of the Leicester cervical smear audit.
    Symonds P; Naftalin N; Shaw P
    BJOG; 2003 Jul; 110(7):646-8. PubMed ID: 12842054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.